Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia

All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only ...

ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIASARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a ...
Clinical Advisor

Beyond the Hit: The Complex Pathophysiology and Management of Sport-Related Concussions

Sport-related concussions are mild traumatic brain injuries that demand timely recognition and management. This review explores current evidence on pathophysiology, diagnosis, and treatment strategies ...

Tampa Bay Functional Neurology Expands Access to Intensive Concussion Recovery Program on Florida’s Gulf Coast

Brandon-based functional neurology clinic introduces a structured fly-in rehabilitation program for post-concussion ...

How has Sidney Crosby played when he returns from injuries? A look at the trends

Sidney Crosby is expected to return soon from a lower-body injury he suffered during the Winter Olympics. Andy Devlin / NHLI via RALEIGH, N.C. — As the Carolina Hurricanes stormed from behind to ...

Oragenics, Inc.: Oragenics Initiates Phase Iia Clinical Trial Site Activation

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...
Technology Networks

Brain Changes From Concussions May Last More Than 10 Years

Researchers found veterans with past concussions showed slower and less accurate eye movements during cognitive tasks, even after a decade. The results suggest eye movement assessments could help ...
Mena FN

Investornewsbreaks Oragenics Inc. (NYSE American: OGEN) Initiates First Clinical Site For Phase Iia Trial Of ONP-002 In Australia

(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics using proprietary intranasal delivery technology, ...
SABC Sport on MSN

Justin Clarke: I’m not a gentleman in a savage sport anymore

Heavyweight powerhouse Justin Clarke is ready to erase the memory of his last fight by reclaiming momentum as the PFL Africa ...
TMCnet

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION

The Company's portfolio expansion initiative is being pursued independently of its existing partnership with Receptor.AI, which focuses on artificial intelligence-enabled CNS drug discovery. Together, ...